VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Positive Topline Results from the Pivotal Phase 3 REDUCE 2 Study of Pozdeutinurad in Gout
Positive Topline Results from the Pivotal Phase 3 REDUCE 2 Study of Pozdeutinurad in Gout
May 22, 2026 04:51 CST Updated 05:39
Share:
